70 Investor presentation Full year 2023 Oral semaglutide 50 mg in overw superior body weight reduction i Change in body weight (%) OASIS 1 showed significantly greater weight loss compared to placeb Mean baseline body weight: 105.4kg 0 -1 -3 -6 -9 -12 -15 -18 -1 0 4 8 12 16 20 28 36 44 52 60 68 68* Time since randomisation (weeks) Oral sema 50 mg Placebo Note: Observed data are on-treatment. Week 68* is the body weight change using the trial product estimand Sema: Semaglutide
Download PDF file